Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer

NCT01931046 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Localized Prostate Cancer

Interventions

DRUG: Ad5-SGE-REIC/Dkk3

Sponsor

Momotaro-Gene Inc.

Collaborators

[object Object]